Clinical Study

Evaluation of the Quantitative and Qualitative Alterations in the Fatty Acid Contents of the Sebum of Patients with Inflammatory Acne during Treatment with Systemic Lymecycline and/or Oral Fatty Acid Supplementation

Table 3

Quantitative squalene variation during the study, based on group treatment and visit.

Fatty acidVisitGroup 1 ( )Group 2 ( )Group 3 ( )
Average (sd)Median (min.–max.)Average (sd)Median (min.–max.)Average (sd)Median (min.–max.)

SqualeneD013.5 (6.0)13.7 (3.0–23.2)12.4 (4.1)12.0 (5.3–20.3)14.1 (4.9)14.2 (2.9–20.9)
D3015.5 (3.5)15.5 (9.9–21.1)13.5 (4.0)13.3 (4.5–21.9)13.9 (3.7)14.6 (6.9–19.0)
D6014.2 (4.1)14.8 (7.6–19.6)12.8 (2.8)14.0 (7.9–16.1)14.3 (4.3)13.9 (7.3–25.0)
D9017.0 (3.2)16.6 (13.0–24.1)14.2 (3.2)13.6 (8.1–19.1)14.0 (6.0)14.9 (1.4–23.0)